Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid... see more

TSXV:MIR - Post Discussion

MedMira Inc > Question
View:
Post by Red~One on Feb 07, 2021 1:34pm

Question

From May 27,2020 NR;  "In early May, MedMira has submitted an application to obtain FDA Emergency Use Authorization (EUA), however, while awaiting the approval, REVEALCOVID-19™ Total Antibody Test can be distributed in the U.S. according to Section IV.D of the Policy for Coronavirus Disease-2019 Test."

From Dec 30/2020 NR:"To ensure the EUA application for the enhanced product, REVEALCOVID-19™ PLUS Total Antibody Test, satisfies the EUA guidelines, MedMira is required to withdraw the current application for the REVEALCOVID-19 TM from the EUA notification list to obtain a new EUA listing for the REVEALCOVID-19 TM PLUS Total Antibody Test. At the same time, MedMira will submit a new interim order application to seek Health Canada authorization of REVEALCOVID-19 TM PLUS Total Antibody Test."

From January 29/2021 News Release:"Regulatory update as well as the latest product development strategy will be publicly announced soon."

EUA Application implied but not stated so do we now have the right to distrube in the USA based on 
Section IV.D of the Policy for Coronavirus Disease ?
Comment by Nathaniel13 on Feb 07, 2021 4:53pm
The application was made prior to Jan 15th as confirmed my MM. I don't know exactly what date. They have not relieved the acknowledgment letter from FDA, which provides them with the right to sell under the guidelines. Don't worry--the FDA has been very public about their efforts to assess the impact of the new variants on approved products and haven't issued EUAs for about 3 weeks ...more  
Comment by Rossaporino on Feb 07, 2021 6:17pm
Thank you sir. For all the information  I feel so good to see and read all these information  I believe in small business opportunities and Medmira will   be remarkable company  as Mr chan said the goal to be billion dollars company and  a with all experience they have , they are in in business for decades  . The test was developed and validated using ...more  
Comment by Red~One on Feb 07, 2021 6:36pm
Thanks for sharing this N....so did they confirm the EUA submission for the Plus test at the meeting Friday or anywhere else. I don't see it mentioned in any NR's Thanks R
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities